Alzheimer’s Biomarkers are Ready for Research
| Date: | March 7, 2012 |
| Related Topics: | Aging Research Alzheimer's Disease Brain Health Drug Development Drug Safety Health Medical Innovation Policy Research |
» Download (MP3 | 10.36 MB)
In a March 1st interview, Dr. John Morris, co-chair of the Alzheimer's Disease Biomarker Expert Working Group (convened by the Alliance for Aging Research), explains what biomarkers are and how they will help research in the field of Alzheimer's disease and related dementia.
John C. Morris is the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology, Professor of Pathology and Immunology, Professor of Physical Therapy, and Professor of Occupational Therapy at Washington University. He also is the Director and Principal Investigator of the Alzheimer's Disease Research Center.
For More info on the promise of biomarkers in Alzheimer's, click here.
John C. Morris is the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology, Professor of Pathology and Immunology, Professor of Physical Therapy, and Professor of Occupational Therapy at Washington University. He also is the Director and Principal Investigator of the Alzheimer's Disease Research Center.
For More info on the promise of biomarkers in Alzheimer's, click here.
Living Longer and Loving It!
Sign up for the Alliance's quarterly newsletter and get timely information on advancements in science, treatment, and health policy that help you "Live Longer and Love It."